3M
(NYSE: MMM)
Health Care announced that its Medical Solutions Division received a $34.2 million award from the U.S. Army Medical Research Acquisition Activity.
The award enables 3M to develop a range of new solutions for infection prevention, wound management and wound healing. St. Paul, Minnesota-based 3M plans to lead a program focused on treatment strategies for use in austere settings. This includes those related to mass casualty and delayed evacuation situations.
Additionally, 3M expects its program to assess biofilm control, biomarker monitoring and health in acute trauma situations. It highlighted blasts, burns and gunshot wounds occurring in civilian and military settings.
3M will collaborate with the University of Minnesota Medical School, the 59th Medical Wing Science & Technology Office of the Chief Scientist (59MDW/ST, lead military partner), Naval Medical Research Unit-San Antonio (NAMRU-SA) and The University of Texas Health Science Center at San Antonio (UT Health San Antonio) in this program. The award supports four separate product solutions. Studies range from prototype and formulation development to clinical studies for product registration.
The company plans to have at least six principal investigators leading studies at three U.S. sites. 3M’s program includes more than 125 support personnel for research efforts between 2023 and 2027.
“Successful treatment of acute, traumatic wounds requires a continuum of care that begins with easy-to-use dressings and effective infection prevention that can be applied at the point of injury, continues with portable solutions for transport, and transitions to more sophisticated solutions in hospital settings suitable for rehabilitation and reintegration of patients,” said Raymond Chiu, SVP, R&D, 3M Health Care. “3M is proud to be working with civilian and military partners to bring these solutions to fruition.”